$16.08
-0.46-2.78%
At close: -
$16.08
0.000.00%
After Hours: Dec 20, 4:01 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Avanos Medical (AVNS) was reported on October 30, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $1.30 to $1.35, compared to the estimated EPS of $1.39. Additionally, Avanos Medical forecasted revenue between $0.68B and $0.69B for the quarter.
Browse guidance and forecast on all stocks.